Rogel Cancer Center Researchers Present at AACR Annual Meeting
Media contact: Anna Megdell, 734-764-2220 | Patients may contact Cancer AnswerLine 800-865-1125
The 2023 AACR meeting runs from April 14 - 19, 2023
Rogel Cancer Center faculty and trainees will lead over two dozen presentations, posters and moderated sessions at the American Association for Cancer Research annual meeting. This year’s meeting will be held in-person.
Check out the list of U-M presenters to support your colleagues. Connect with researchers on Twitter using #AACR23. Be sure to tag @UMRogelCancer.
Presenter information is sometimes incomplete. If your session is missing, please email the abstract link to [email protected].
April 15
ED025 - Innovations in Methods for Adapting and Personalizing Interventions for Cancer Control
Inbal Nahum-Shani, Chair and Presenter
10:00 AM – 11:30 AM
Room W312 - Convention Center
Making phase I trials relevant: Aligning need with design
Thomas M. Braun
10:05 AM – 10:25 AM
Valencia D - Convention Center
Establishment and regulation of the pancreatic cancer microenvironment
Marina Pasca Di Magliano
12:30 PM – 12:50 PM
Tangerine Ballroom 2 (WF2) - Convention Center
April 16
MS.ET09.01 - Small Molecule Therapeutic Agents
Judy Leopold, Chair
3:00 PM – 5:00 PM
Room W224 - Convention Center
1160 - A machine learning based method for in-vivo metabolic flux analysis of patient tumors
Anjali Mittal
4:07 PM – 4:22 PM
Room W304 A-D - Convention Center
Poster Session, 1:30-5:00 PM
Abha Kumari
Section 41
1068 / 12 - A precision CRISPR approach to target structural variant junctions in cancer
Radhika Suhas Hulbatte
Section 43
Minal Nenwani
Section 44
1093 / 6 - Measuring and inhibiting purine metabolism in patients with glioblastoma
Daniel R. Wahl
Section 44
1095 / 8 - Exploiting altered methionine metabolism to overcome treatment resistance in glioblastoma
Navyateja Korimerla
Section 44
595 / 29 - Targeting metabolic vulnerability in brain-metastatic HER2+ breast cancer
Habib Serhan
Section 20
331 / 11 - Mitochondrial transfer from astrocytes drives glioblastoma tumorigenicity
Dionysios C. Watson
Section 12
April 17
AOS09 - Informing Future Precision Medicine Trials for Pancreatic Cancer
Marina Pasca di Magliano
10:45 AM – 11:05 AM
Valencia BC - Convention Center
SY13 - New Horizons for T Cell Immunity and Checkpoints
Weiping Zou
1:00 PM – 1:20 PM
Tangerine Ballroom 2 (WF2) - Convention Center
MS.CH01.01 - New Targeted Protein Degraders: Discovery and Novel Design Strategies
Yu Chang
3:37 PM – 3:52 PM
Room W224 - Convention Center
MS.MD01.02 - Molecular Pathway Discovery and Translation in Solid Tumors
3:21 PM – 3:36 PM
Weihua Zhou
Room W304 A-D - Convention Center
Yu Leo Lei
6:50 PM – 7:00 PM
Windermere X - Hyatt Regency
Poster Session, 9:00 AM - 12:30 PM
Michael Mumphrey
Section 32
Jin Heon Jeon
Section 31
Nna-Emeka Onukwugha
Section 39
2115 / 18 - Zero-waste molecular diagnostics from biopsy needle wash water
Jack Wadden
Section 38
2256 / 3 - Cancer stem cells and exosomal PD-L1 suppress anti-tumor B cells
Ying Xin
Section 43
2279 / 26 - Tumor treating fields induce immune modulation in non-small cell lung cancer
Suhe Wang
Section 43
2236 / 13 - The role of CPI-613 in cholangiocarcinoma treatment
Fulei Wuchu
Section 42
Ryan J. Rebernick
Section 42
Noah Puleo
Section 19
1685 / 10 - Overcoming acquired resistance to PROTAC degraders
Tongchen He
Section 19
Yun Zhang
Section 21
Jessica Teitel
Section 15
Caleb Cheng
Section 17
1501 / 28 - Epigenetic dedifferentiation as a therapeutic strategy in adrenal cancer
Dipika R. Mohan
Section 12
Ehsanul Hoque Apu
Section 5
Poster Session, 1:30 PM - 5:00 PM
Yu Zhang
Section 36
Scott M. Smith
Section 41
Neha Nagpal
Section 42
Daniel J. Herr
Section 47
Erik R. Peterson
Section 19
Kassidy M. Jungles
Section 19
2401 / 1 - Molecular mechanisms of intrinsic radioresistance in breast cancer
Breanna N. McBean
Section 3
April 18
AOS01 - Advances in Brain Tumor Research and Treatment
Carl Koschmann
12:35 PM – 12:55 PM
Room W307 - Convention Center
AACR James S. Ewing-Thelma B. Dunn Award for Outstanding Achievement in Pathology in Cancer Research
Arul M. Chinnaiyan
5:15 PM
Poster Session 9:00 AM - 12:30 PM
Samuel B. Reynolds
Section 44
3909 / 28 - THY1 regulates therapy resistance in glioblastoma recurrence
Sunita Shankar
Section 16
Andrew J. Scott
Section 7
Hsiangyu Hu
Section 2
Matthew Pun
Section 1
Poster Session, 1:30 PM - 5:00 PM
Wenjin Gu
Section 35
Harrison Ball
Section 41
5502 / 20 - Androgen blockade confers sensitivity to PIKfyve inhibition in prostate cancer
Yuanyuan Qiao
Section 38
Allison May
Section 7
Andi Cani
Section 41
Erin Giles
Section 27
April 19
ADT09 - Technical Advances in Liquid Biopsy and Rare Event Detection
Sunitha Nagrath, Chair and Presenter
10:15 AM – 11:45 AM
Room W414 - Convention Center
Poster Session 9:00 AM - 12:30 PM
6141 / 3 - Mechanisms by which Mito-lonidamine inhibits EGFR mutant lung cancer
Katherine M. Weh
Section 16
Miranda L. Simes
Section 20
6423 / 10 - Targeting an autophagy regulator augments antitumor immunity and immunotherapy
Yi Bao
Section 25
Abhinav Achreja
Section 11
6529 / 27 - Early life liver proteomic signature and minerals mitigation of liver injury
Muhammad N. Aslam
Section 28
Xinman Zhang
Section 27
Syed M. Faisal
Section 3